活体内磷脂酰胆碱替代磷脂酰乙醇胺影响E.coli细胞的功能

【目的】通过磷脂酰胆碱(PC)阳性大肠杆菌菌株与磷脂酰乙醇胺(PE)阳性野生型和PE阴性突变型菌株比较,并用PC+PE+双阳性菌株佐证,从细菌形态、生理生化以及巨噬细胞对细菌的吞噬作用等方面探讨活体内磷脂酰胆碱能否替代磷脂酰乙醇胺。【方法】光学和电子显微镜观察细菌形态和结构;不同条件培养细菌并使用分光光度计测定OD600值,评估细菌的生长情况;使用SDS-PAGE和2-D电泳法测定细菌间质蛋白组分;用小鼠RAW264.7巨噬细胞系检测细菌的粘附和吞噬作用。【结果】与短棒状的PE+野生型细菌AD93/pDD72相比,PC+细菌AD93/ptac67中仍有25%丝状体;与PE-突变体AD93一样,PC+细菌AD93/ptac67仍需要添加二价离子Mg2+或Ca2+才能生长;与野生型AD93/pDD72相比,PC+细菌AD93/ptac67的周质蛋白组分、粘附率与相对吞噬效率呈现明显的差异;与野生型细菌Top10/ptac85相比,PE+PC+双阳性细菌Top10/ptac66的细胞壁外层、抗逆性和周质蛋白组分也显示差别。【结论】在活体内,膜磷脂中PC替代PE不能使PE-突变体细胞的功能完全恢复至野生型状态,PE和PC在功能上存在明显的差别,两者在功能上不能相互替代。     

掺入大肠杆菌膜中的磷脂酰胆碱(PC)影响青霉素b-内酰胺酶的分泌

[目的]为了研究磷脂酰胆碱(PC)在原核生物细胞中的生物学作用,探讨PC对细菌膜系统的功能的影响.[方法]使用ptac 85质粒作载体,将螺旋菌pcs基因导入E.coli Top10细胞构建了E.coli Fop10 pcs 菌株,并在特定的条件下培养细菌,使细菌膜磷脂中合成30%左右的磷脂酰胆碱.然后再使用抗生素抗性分析、β-内酰胺酶的酶活测定以及Western blot杂交技术,分析质粒编码的β-内酰胺酶从细胞质到细胞问质的分泌情况.[结果]抗生素抗性分析发现,高浓度的氨苄青霉素抑制E.coliTop10 pcs 细菌的生长的氨苄青霉素剂量低于对照组,其半致死剂量IC50在700～800μg/mL之间.酶活检测显示E.coli Top10 pcs 细菌周质内β-内酰胺酶的酶活性只有对照菌株的1,5,Western blot进一步分析发现周质内β-内酰胺酶的含量也为对照菌株的1/5.由此可见,周质内低含量的β-内酰胺酶是导致E.coli Top10pcs 细菌氨苄青霉素抗性降低的原因.[结论]掺入细菌膜磷脂双分子层的PC影响p.内酰胺酶通过Sec转运途径从细胞质分泌到细菌周质空间内,提示细菌磷脂酰胆碱可能在调节蛋白转运和分泌方面起着重要的作用.     

红色红曲菌M7的丝衣霉酸基因簇及其功能研究

【目的】明确红色红曲菌(Monascus ruber) M7的基因组中是否存在丝衣霉酸(byssochlamic acid, BA)基因簇,并探讨BA基因簇中聚酮合酶基因mr-Bys及3-羟酰基辅酶A脱氢酶基因mr-hdh对BA产生的影响。【方法】采用生物信息学方法对M7基因组进行分析,以确定BA候选基因簇;以基因敲除及过表达方法研究mr-Bys和mr-hdh对BA产生的影响;以超高效液相色谱(ultra-performance liquid chromatography, UPLC)和质谱(mass spectrometry, MS)方法分析BA。【结果】在红色红曲菌M7基因组中发现了BA基因簇,敲除mr-Bys后,BA消失,而敲除和过表达mr-hdh均可影响BA的产生。【结论】红色红曲菌M7基因组中存在BA基因簇,可产生BA。研究结果不仅丰富了红曲菌次生代谢产物及其合成途径的相关研究,也为以红曲菌为菌种开发新产品奠定了基础。     

磷脂酰胆碱对兔骨骼肌肌质网钙泵磷酸化微区分子运动的影响

用毫微秒荧光分光光度计研究了精制兔骨骼肌肌质网钙泵的分子内微细结构及周围磷脂对分子内运动状态的影响.磷脂酰胆碱的置换,导致钙泵脂酶体膜微粘度下降,磷脂分子运动增强,膜流动性增加.di(20:4)PC置换基本未改变钙泵分子内磷酸化微区(Domain)的运动状态.短链磷脂置换使钙泵酸化微区运动加速.结果提示,磷脂分子的平均链长是影响钙泵酸化微区运动状态的重要因素;不饱和度对分子内运动几无影响.     

抗甲磺隆假单胞菌的分离及其乙酰乳酸合酶的大小亚基ilvIH基因的克隆和表达

乙酰乳酸合酶(也称乙酰羟酸合酶acetohydroxyacid synthase,AHAS)是植物、真菌和细菌细胞内支链氨基酸Val、Leu、Ile生物合成过程中关键酶,是乙酰乳酸合酶抑制剂类除草剂如磺酰脲类、咪唑啉酮类、嘧啶水杨酸和磺酰氨类的作用靶标.[目的]获得抗甲磺隆的乙酰乳酸合酶基因,构建其表达载体,并分析基因中的位点突变与乙酰乳酸合酶对磺酰脲类除草剂抗性产生原因.[方法]从长期使用甲磺隆的土壤中分离到l株抗甲磺隆的菌株Lm10,利用PCR技术从Lm10总DNA中克隆到乙酰乳酸合酶的大小亚基基因ilvIH,对ilvIH氨基酸序列进行比对分析.分别将ilvI和ilvH分别连接到表达载体pET29a( )多克隆位点,转化大肠杆菌(Escherichia coli)获得转化子BL21(pET-I)和BL21(pET-H),并诱导表达.[结果]菌株Lm10鉴定为假单孢菌(Pseudomonas sp.),对甲磺隆的最高耐受浓度达到14000 μmol/L,且对各种乙酰乳酸合酶抑制剂类除草剂具有交叉抗性.Lm10与甲磺隆敏感菌株KT2440的小亚基氨基酸序列完全相同,而大亚基有6个氨基酸位点发生变异.转化子在IPTG诱导下,乙酰乳酸合酶的大小亚基的蛋白成功表达,粗酶液酶活试验结果表明Lm10的ilvI基因表达的乙酰乳酸合酶大亚基对甲磺隆有很强的抗性.[结论]发现菌株Lm10的乙酰乳酸合酶大亚基对甲磺隆有很强的抗性,抗甲磺隆菌株Lm10与敏感菌株KT2440的ilvI有6个氨基酸位点差异,这些位点突变可能是乙酰乳酸合酶对甲磺隆抗性产生的原因.     

代谢工程改造酿酒酵母提高法尼醇产量

【目的】法尼醇(FOH,C_(15)H_(26)O)是一种具有芳香气味的非环状倍半萜醇,被广泛应用于化妆品和医学药物的工业化生产,也可作为航空燃料的理想替代品。具有食品级安全性的酿酒酵母细胞能够合成内源性法尼醇,但其产量很低,无法满足工业生产的需要。因此,需要采用代谢工程手段,改造法尼醇合成途径,以有效提高法尼醇在酿酒酵母中的产量。【方法】以酿酒酵母工业菌株CEN.PK2-1D为底盘细胞,强化甲羟戊酸途径中关键酶的表达水平和弱化麦角固醇合成分支途径,以提高法尼醇合成所需的直接前体物质法尼基焦磷酸(FPP);并分别表达催化FPP合成法尼醇的五种内源磷酸酶和两种异源合酶,筛选能高效合成法尼醇的磷酸酶或合酶。【结果】通过在CEN.PK2-1D(法尼醇产量0.1mg/L)中强化表达甲羟戊酸途径中截短形式的HMG-CoA还原酶(tHMGR1)和FPP合酶(ERG20),使法尼醇产量提高约50.8倍,达到5.08 mg/L;使用HXT1启动子替换鲨烯合酶编码基因ERG9启动子以下调其表达水平,使法尼醇产量进一步提升47.1倍,达到239.17 mg/L。在此基础上,筛选发现,表达酿酒酵母内源性磷酸酶PAH1时,获得最高产量法尼醇,达到393.13 mg/L。【结论】采用代谢工程策略对酿酒酵母法尼醇合成途径进行改造,有效提高法尼醇产量至393.13 mg/L,为目前报道的在酿酒酵母中摇瓶培养条件下的最高产量。     

灰葡萄孢菌AUR1基因内含子对肌醇磷脂酰神经酰胺合成酶表达的影响及致病性

【目的】AUR1编码的肌醇磷脂酰神经酰胺(IPC)合成酶是真菌鞘脂代谢的关键酶,在转录水平和翻译水平研究AUR1内含子对其基因表达的影响,以及AUR1内含子对相关致病因子的影响,为内含子调控基因表达的分子机制提供理论依据。【方法】实时定量PCR测定野生型灰葡萄孢菌(BcAUR1)和AUR1缺失115 bp内含子突变体(BcAUR1a)的mRNA表达量,高效液相层析测定IPC合成酶活性,分别采用辣根过氧化物酶法、邻苯三酚自氧化法、愈创木酚法和紫外分光光度法测定单位菌体的H2O2含量、超氧化物歧化酶(SOD)、过氧化物酶(POD)和过氧化氢酶(CAT)的酶活力。【结果】突变体BcAUR1a的IPC合成酶基因cDNA测序结果表明,IPC合成酶无氨基酸突变。实时定量PCR和高效液相层析的结果表明BcAUR1a的AUR1基因mRNA表达量和IPC合成酶活力比野生型BcAUR1分别增加了50.2%和14.16%。短梗霉素A(AbA)显著刺激BcAUR1 H2O2、SOD、POD和CAT的分泌,但对BcAUR1a的这几种物质的分泌无显著影响。【结论】突变体BcAUR1a的AUR1基因在转录和翻译水平上表达上调,AbA显著增强野生型灰葡萄孢菌致病力,但对突变体影响较小。突变体产生了对AbA的抗性,推测AUR1基因内含子在AUR1基因表达调控中起转录抑制子的作用。     

基于结构B因子分析指导的头孢菌素C酰化酶动力学稳定性改造

【目的】筛选Pseudomonas sp.SE83 acy Ⅱ定点饱和突变库,获得动力学稳定性提高的头孢菌素C(CPC)酰化酶突变体,并对突变酶进行初步的结构-功能关系分析。【方法】靶标酶Pseudomonas sp.SE83 acy Ⅱ与Pseudomonas diminuta N176具有较高的同源性,通过分析N176的结构B因子,构建CPC酰化酶SE83定点饱和突变库;基于pH指示剂显色法,采用Biomek FX~P自动工作站建立CPC酰化酶高通量筛选方法,获得优良突变酶,对其活性、稳定性等酶学性质进行表征;利用SWISS-MODEL对突变体进行同源建模,探讨突变体结构与功能的关系。【结果】通过B因子分析和同源结构比对,共找出9个靶标位点;经过3轮筛选,发现R218及K226位点突变显著提高酶的热稳定性,其中最显著的R218Q和K226V在40°C的半衰期分别为野生型的3.77和2.77倍,催化效率k_(cat)/K_m分别为野生型的1.8和3.1倍。同源建模分析表明氢键作用和疏水相互作用的增加可能是突变体稳定性提高的原因。【结论】B因子指导的酶分子改造是一种高效可靠的动力学稳定性改造策略,突变体R218Q和K226V均可提高CPC酰化酶的稳定性和催化效率,对进一步的CPC酰化酶分子改造具有一定的参考价值和指导意义。     

磷脂酰肌醇转移蛋白

磷脂酰肌醇转移蛋白(phosphatidylinositol/phosphatidylcholine transfer proteins,PITP)普遍存在于真核生物细胞中,PITP能够结合并交换一分子的磷脂酰肌醇(phosphatidylinositol,PI)或磷脂酰胆碱(phosphatidylcholine,PC),并促进这两类脂分子在细胞内膜组分间的转移。PITP对细胞内膜组分间脂类的运输和代谢、分泌囊泡的形成和运输、磷脂酶C(phospholipase,PLC)调节的信号传导以及神经退化等生理生化过程具有重要的影响。综述了近年来PITP的研究进展,并对目前研究中存在的一些问题进行探讨。     

探索大肠杆菌细胞膜合成过程中脂肪酸的掺入模式

【目的】探索大肠杆菌生长分裂过程中,脂肪酸作为底物在细胞膜合成过程中的掺入模式。【方法】本研究解析了以乙酰CoA为底物,合成中间产物长链脂酰-ACP,随后合成磷脂酰乙醇胺(phosphatidylethanolamine,PE)的途径,并将合成途径中的10个关键酶与绿色荧光蛋白(enhanced green fluorescent protein,EGFP)或红色荧光蛋白(monmer Cherry,mCherry)进行融合,在大肠杆菌内表达这些融合蛋白,用激光共聚焦荧光显微镜成像的方式来获得这些融合蛋白的定位信息。【结果】宽场荧光显微镜成像结果显示,磷脂酰乙醇胺合成途径中的10个酶在不同表达水平下出现不同的定位模式。在大肠杆菌中高水平表达融合蛋白EGFP-FabA、EGFP-FabB、EGFP-FabI、EGFP-FabG、EGFP-PlsB和EGFP-PssA时,细胞两极和中部有大量蛋白聚集的现象。EGFP-FabD、EGFP-FabF、EGFP-CdsA、EGFP-PSD在不同表达水平下,均匀分散在细胞质或细胞膜上。缩时影像(Time-lapse)结果显示,合成途径中的一个关键蛋白EGFP-Pls B在细胞分裂前随着细胞膜的内陷聚集到细胞隔膜,随着细胞分裂,母细胞的隔膜成为新细胞的两极。【结论】本研究通过获取磷脂酰乙醇胺合成相关蛋白酶在大肠杆菌中的定位结果,推测脂肪酸分子是在细胞分裂隔膜和两极掺入,被催化合成PE后被运送到细胞膜其他位置。     

Cloning and characterization of the gene for phosphatidylcholine synthase

Phosphatidylcholine (PC) is the major membrane-forming phospholipid in eukaryotes and can be synthesized by either of two pathways, the CDP-choline pathway or the methylation pathway. In prokaryotes only the methylation pathway was thought to occur. Recently, however, we could demonstrate (de Rudder, K. E. E., Sohlenkamp, C., and Geiger, O. (1999) J. Biol. Chem. 274, 20011-20016) that a second pathway for phosphatidylcholine biosynthesis exists in Sinorhizobium (Rhizobium) meliloti involving a novel enzymatic activity, phosphatidylcholine synthase, that condenses choline and CDP-diacylglyceride in one step to form PC and CMP. Using a colony autoradiography method we have isolated mutants of S. meliloti deficient in phosphatidylcholine synthase and which are no longer able to incorporate radiolabeled choline into PC. Complementation of such mutants with a sinorhizobial cosmid gene bank, subcloning of the complementing fragment, and sequencing of the subclone led to the identification of a gene coding for a presumptive CDP-alcohol phosphatidyltransferase. Amplification of this gene and its expression in Escherichia coli demonstrates that it codes for phosphatidylcholine synthase. Genomes of some pathogens (Pseudomonas aeruginosa and Borrelia burgdorferi) contain genes similar to the sinorhizobial gene (pcs) for phosphatidylcholine synthase. Although pcs-deficient S. meliloti knock-out mutants show wild type-like growth and lipid composition, they are unable to perform rapid PC biosynthesis that normally is achieved via the phosphatidylcholine synthase pathway in S. meliloti wild type.     

Brucella abortus synthesizes phosphatidylcholine from choline provided by the host

The Brucella cell envelope is characterized by the presence of phosphatidylcholine (PC), a common phospholipid in eukaryotes that is rare in prokaryotes. Studies on the composition of Brucella abortus 2308 phospholipids revealed that the synthesis of PC depends on the presence of choline in the culture medium, suggesting that the methylation biosynthetic pathway is not functional. Phospholipid composition of pmtA and pcs mutants indicated that in Brucella, PC synthesis occurs exclusively via the phosphatidylcholine synthase pathway. Transformation of Escherichia coli with an expression vector containing the B. abortus pcs homologue was sufficient for PC synthesis upon induction with IPTG (isopropyl-beta-d-thiogalactopyranoside), while no PC formation was detected when bacteria were transformed with a vector containing pmtA. These findings imply that Brucella depends on choline provided by the host cell to form PC. We could not detect any obvious associated phenotype in the PC-deficient strain under vegetative or intracellular growth conditions in macrophages. However, the pcs mutant strain displays a reproducible virulence defect in mice, which suggests that PC is necessary to sustain a chronic infection process.     

Novel pathway for phosphatidylcholine biosynthesis in bacteria associated with eukaryotes

Phosphatidylcholine (PC) is the major membrane-forming phospholipid in eukaryotes and can be synthesised by either of two pathways, the CDP-choline pathway or the methylation pathway. Many prokaryotes lack PC, but it can be found in significant amounts in membranes of distantly related bacteria such as Rhizobacteria and Spirochetes. Enzymatic methylation of phosphatidylethanolamine via the methylation pathway was thought to be the only biosynthetic pathway to yield PC in bacteria. However, a novel choline-dependent pathway for PC biosynthesis has been discovered in Sinorhizobium meliloti. In this pathway, a novel enzymatic activity, PC synthase, condenses choline directly with CDP-diacylglyceride to form PC in one step. Surprisingly, genomes of some pathogens (Pseudomonas aeruginosa, Borrelia burgdorferi and Legionella pneumophila) contain genes similar to the sinorhizobial gene for phosphatidylcholine synthase. We, therefore, suggest that the new PC synthase pathway is present in a number of bacteria displaying symbiotic or pathogenic associations with eukaryotes and that the eukaryotic host functions as the provider of choline for this pathway.     

LASS5 is the predominant ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia

Ceramide is a key bioactive mediator that inhibits surfactant phosphatidylcholine (PtdCho) synthesis in lung epithelia. Ceramide availability is governed by sphingomyelin (SM) hydrolysis, but less is known regarding its de novo synthesis. In this study, we observed that ceramide synthesis within murine lung epithelia was associated with high-level ceramide synthase (dihydroceramide synthase) activity. Longevity assurance homolog 5 (LASS5) was the predominant ceramide synthase isoform detected in lung epithelia, whereas relatively lower level expression was detected for the other five mammalian homologs. Pulmonary LASS5 was developmentally regulated, but its expression was spatially and gender nonspecific. Exogenously expressed LASS5 in lung epithelia was membrane-associated, triggering increased ceramide synthesis, whereas knockdown studies using fumonisin B1 or LASS5 small, interfering RNA reduced ceramide synthase activity by 78% or 45%, respectively. Overexpression of LASS5 also reduced PtdCho synthesis, but maximal inhibition was achieved when LASS5 was coexpressed with a plasmid encoding a neutral sphingomyelinase involved in SM hydrolysis. These results demonstrate that LASS5 is the major ceramide synthase gene product involved in sphingolipid production that may also regulate PtdCho metabolism in pulmonary epithelia.     

Sphingomyelin synthases 1 and 2 exhibit phosphatidylcholine phospholipase C activity

Many studies have confirmed the enzymatic activity of a mammalian phosphatidylcholine (PC) phospholipase C (PLC) (PC-PLC), which produces diacylglycerol (DAG) and phosphocholine through the hydrolysis of PC in the absence of ceramide. However, the protein(s) responsible for this activity have never yet been identified. Based on the fact that tricyclodecan-9-yl-potassium xanthate can inhibit both PC-PLC and sphingomyelin synthase (SMS) activities, and SMS1 and SMS2 have a conserved catalytic domain that could mediate a nucleophilic attack on the phosphodiester bond of PC, we hypothesized that both SMS1 and SMS2 might have PC-PLC activity. In the present study, we found that purified recombinant SMS1 and SMS2 but not SMS-related protein have PC-PLC activity. Moreover, we prepared liver-specific Sms1/global Sms2 double-KO mice. We found that liver PC-PLC activity was significantly reduced and steady-state levels of PC and DAG in the liver were regulated by the deficiency, in comparison with control mice. Using adenovirus, we expressed Sms1 and Sms2 genes in the liver of the double-KO mice, respectively, and found that expressed SMS1 and SMS2 can hydrolyze PC to produce DAG and phosphocholine. Thus, SMS1 and SMS2 exhibit PC-PLC activity in vitro and in vivo.     

Functional and topological analysis of phosphatidylcholine synthase from Sinorhizobium meliloti

Phosphatidylcholine (PC) is the major membrane-forming phospholipid in eukaryotes and is estimated to be present in about 15% of eubacteria. It can be synthesized in bacteria by either of two pathways, the phospholipid N-methylation pathway or the phosphatidylcholine synthase (Pcs) pathway. Pcs belongs to the CDP-alcohol phosphotransferase superfamily and synthesizes PC and CMP in one step from CDP-diacylglycerol and choline. In this study, we aligned sequences of characterized Pcs enzymes to identify conserved amino acid residues. Alanine scanning mutagenesis was performed on 55 of these conserved residues. The mutation of nine residues caused a drastic to complete loss (< 20% of wild type activity) of Pcs activity. Six of these essential residues were subjected to further mutagenesis studies replacing them by amino acids with similar properties or size. A topological analysis of sinorhizobial Pcs showed the presence of eight transmembrane helices, with the C- and N-terminus located in the cytoplasm. The majority of the conserved residues is predicted to be either located within the cytoplasmic loops or on the cytoplasmic side of the membrane which can be expected for an enzyme using one membrane-associated and one soluble substrate.     

A CDP-choline pathway for phosphatidylcholine biosynthesis in Treponema denticola

The genomes of Treponema denticola and Treponema pallidum contain a gene, licCA, which is predicted to encode a fusion protein containing choline kinase and CTP:phosphocholine cytidylyltransferase activities. Because both organisms have been reported to contain phosphatidylcholine, this raises the possibility that they use a CDP-choline pathway for the biosynthesis of phosphatidylcholine. This report shows that phosphatidylcholine is a major phospholipid in T. denticola, accounting for 35-40% of total phospholipid. This organism readily incorporated [14C]choline into phosphatidylcholine, indicating the presence of a choline-dependent biosynthetic pathway. The licCA gene was cloned, and recombinant LicCA had choline kinase and CTP:phosphocholine cytidylyltransferase activity. The licCA gene was disrupted in T. denticola by erythromycin cassette mutagenesis, resulting in a viable mutant. This disruption completely blocked incorporation of either [14C]choline or 32Pi into phosphatidylcholine. The rate of production of another phospholipid in T. denticola, phosphatidylethanolamine, was elevated considerably in the licCA mutant, suggesting that the elevated level of this lipid compensated for the loss of phosphatidylcholine in the membranes. Thus it appears that T. denticola does contain a licCA-dependent CDP-choline pathway for phosphatidylcholine biosynthesis.     

Gene cloning, structural gene and promoter identification, and active assay of the phosphatidylcholine synthase of Pseudomonas sp. strain 593

Pseudomonas sp. strain 593, a soil bacterium, is able to use exogenous choline to synthesize phosphatidylcholine via phosphatidylcholine synthase (Pcs). A 2020 bp DNA fragment that hybridized to a Pcs probe was cloned. This fragment contained a large open reading frame (ORF) with two potential ATG start sites that would encode for 293 and 231 amino acid proteins. Fragments containing the two ORFs encoded Pcs when they were inserted into the expression vector pET23a and expressed under the control of the T7 promoter in Escherichia coli BL21(DE3) pLysS. However, when the two ORFs were inserted into the cloning vector pMD18-T and expressed without control of the plasmid promoter in E. coli DH5α, only the larger clone exhibited Pcs activity. This suggested that the larger fragment contained a native promoter driving expression of the smaller ORF. A promoter activity assay, in which DNA fragments were inserted into the promoter-probe plasmid pCB182 and β-galactosidase activity of E. coli transformants was tested, demonstrated that a promoter is indeed present in the DNA region. All results together indicate that the 696 bp ORF, not the larger 897 bp ORF, encodes the Pcs in Pseudomonas sp. strain 593 and carries a promoter in front of its 5' terminus.     

The effect of cholesterol on the structure of phosphatidylcholine bilayers

The effect of cholesterol on the structure of phosphatidylcholine bilayers was investigated by X-ray diffraction methods. Electron density profiles at 5 Å resolution along with chain tilt and chain packing parameters were obtained and compared for phosphatidylcholine/cholesterol bilayers and for pure phosphatidylcholine bilayers in both the gel and liquid crystalline states. The cholesterol in the bilayer was localized by noting the position of discrete elevations in the electron density profiles. Cholesterol can either increase or decrease the width of the bilayer depending on the physical state and chain length of the lipid before the introduction of cholesterol. For saturated phosphatidylcholines containing 12–16 carbons per chain, cholesterol increases the width of the bilayer as it removes the chain tilt from gel state lipids or increases the trans conformations of the chains for liquid crystalline lipids. However, cholesterol reduces the width of 18 carbon chain bilayers below the phase transition temperature as the long phospholipid chains must deform or kink to accomodate the significantly shorter cholesterol molecule. Although cholesterol has a marked effect on hydrocarbon chain organization, it was found that, within the resolution limits of the data, the phosphatidylcholine head group conformation is unchanged by the addition of cholesterol to the bilayer. The head group is oriented parallel to the plane of the bilayer for phosphatidylcholine in the gel and liquid crystalline states and this orientation is not changed by the addition of cholesterol.